早期和晚期结肠直肠癌之间的预后差异
Vlad Alexandru Ionescu1,2, Gina Gheorghe1,2, Ioana-Alexandra Baban3
1Faculty of Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.
Medicina (Kaunas, Lithuania)
|March 27, 2025
概括
早发性结直肠癌 (EO-CRC) 与晚发性结直肠癌 (LO-CRC) 相比,具有明显的攻击性特征. EO-CRC与特定的瘤亚型,HER2阳性和生活方式因素有关,需要量身定制的查和治疗.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 早期结直肠癌 (EO-CRC) 发病率正在上升,这对公众健康构成了重大挑战.
- 与晚发性结直肠癌 (LO-CRC) 相比,EO-CRC通常与更差的预后有关.
- 了解EO-CRC的独特特征对于改善患者的治疗结果至关重要.
研究的目的:
- 确定导致EO-CRC具有攻击性的流行病学,临床和准临床因素.
- 为了比较EO-CRC与LO-CRC的特性.
主要方法:
- 在两年内对204名结直肠癌 (CRC) 患者进行了回顾性研究.
- 患者被分为EO-CRC和LO-CRC分组.
- 使用IBM SPSS统计,版本29.0.0.进行了统计分析.
主要成果:
- EO-CRC占11.3%的病例,并显示出更远端的瘤和狭窄的外观的趋势.
- 在EO-CRC患者中,粘膜组织学 (34.8%与14.4%) 和差异化瘤 (39.1%与14.5%) 的发病率较高.
- 在EO-CRC中观察到HER2阳性增加 (p=0.002) 和CDX2阳性减少 (p=0.012),吸烟和高血压的患病率更高.
结论:
- EO-CRC患者表现出独特的基因病理和分子特征,包括粘膜亚型,差异化和改变的HER2/CDX2表达,导致侵袭性疾病.
- 吸烟和高血压等生活方式因素在EO-CRC患者中更为常见.
- 这些发现支持了针对年轻的CRC患者进行量身定制的查和个性化治疗策略的需要.
相关概念视频
01:21Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
01:20Comparing the Survival Analysis of Two or More Groups
107
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
107
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K